Capital Advantage »

Novartis shares owned by Capital Advantage

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Capital Advantage from 13F filings

Historical chart of Capital Advantage investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Capital Advantage consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Capital Advantage

Quarter filed Position value Share count Share price at filing
2025-09-30 $225k 1.8k 128.24
2025-06-30 $213k 1.8k 121.01

More positions owned by Capital Advantage

Vanguard Scottsdale Fds Int-term Corp (VCIT)
Capital Grp Fixed Incm Etf T Us Multi-sector (CGMS)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Whitehall Fds Intl Dvd Etf (VIGI)
Vanguard Whitehall Fds Intl High Etf (VYMI)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Specialized Funds Div App Etf (VIG)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Select Sector Spdr Tr Financial (XLF)
Vanguard World Health Car Etf (VHT)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Spdr Series Trust Portfolio S&p500 (SPLG)
Vanguard World Industrial Etf (VIS)
Vanguard World Mega Cap Index (MGC)
Apple (AAPL)

View all positions for Capital Advantage

Top funds holding Novartis

Dodge & Cox
PRIMECAP Management Company
Dimensional Fund Advisors
Morgan Stanley
Fisher Investments
Loomis, Sayles and
Franklin Resources
Goldman Sachs Group
BlackRock
Northern Trust
GQG Partners
Principal Financial Group
Cullen Capital Management
Henderson Group
Renaissance Technologies

View all funds holding Novartis